Fact CheckerSign in

NCT06702696Recruiting

Effect of Aronia Berry Consumption on Inflammatory Parameters

Consumption of Anti-Inflammatory Effects of Aronia (Aronia Melanocarpa) Berry in Patients With Chronic Obstructive Pulmonary Disease

Source: ClinicalTrials.gov · Last updated 1 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The study will aim to evaluate the effects of consuming freeze-dried aronia berries as an adjunct to medical treatment in patients with chronic obstructive pulmonary disease (COPD), focusing on anti-inflammatory, respiratory, and biochemical parameters. It will be conducted at a research hospital in Istanbul, involving 50 participants aged 50-80 diagnosed with COPD. Participants will be randomly assigned to two groups: the aronia group (AG, n=25) and the placebo group (PG, n=25). The AG will receive 30 g of freeze-dried aronia powder daily, while the PG will receive 30 g of placebo powder, both for a duration of 8 weeks. Baseline demographic data will be collected through face-to-face interviews, while biochemical, respiratory, anthropometric, and body composition parameters will be assessed both before and after the intervention. Dietary intake records will also be collected and analyzed.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
18 Nov 2024
Start date
15 Nov 2024
Primary completion date
15 Sept 2025
Lead sponsor
Amasya University
Diseases
COPD
NCT number
NCT06702696

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 15 Nov 2024 to the primary completion date, 15 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of associated chronic inflammatory/rheumatic diseases
  • Chronic infections that may create a prothrombotic state
  • Chronic kidney disease (CKD)
  • Malignancy
  • Diagnosed endocrine disorders
  • Malabsorption disorders
  • Allergy to any food or berry fruits

Other

  • Hereditary thrombophilia
  • Essential thrombocythemia
  • Smoking
  • Participants who did not sign the informed consent form

Who the study is looking for

  • Aged 50-80 years
  • Diagnosed with COPD
  • Not following a vegetarian or vegan diet
  • Willing to consume the provided aronia berry (black chokeberry)
  • Non-smokers
  • Have signed the informed consent form
  • Has not undergone endobronchial tube or valve surgery in the last two years.

Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Yedikule Göğüs Hastalıkları Hastanesi
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.